Upload Image (Max 20MB per Image)
The National Institute for Health and Clinical Excellence (NICE) in the UK, has issued an Appraisal Consultation Document (ACD) recommending that Afinitor (everolimus), a Novartis’ life extending advanced breast cancer treatment ...
Tags: Novartis breast cancer, drug, therapeutic drug